Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection.
H7N9 has caused fatal infections in humans. A safe and effective vaccine is the best way to prevent large-scale outbreaks in the human population. Parainfluenza virus 5 (PIV5), an avirulent paramyxovirus, is a promising vaccine vector. In this work, we generated a recombinant PIV5 expressing the HA...
Main Authors: | Zhuo Li, Jon D Gabbard, Scott Johnson, Daniel Dlugolenski, Shannon Phan, S Mark Tompkins, Biao He |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0120355 |
Similar Items
-
Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain.
by: Brett D Welch, et al.
Published: (2013-01-01) -
Parainfluenza 3-Induced Cough Hypersensitivity in the Guinea Pig Airways.
by: Eric J Zaccone, et al.
Published: (2016-01-01) -
PLK1 down-regulates parainfluenza virus 5 gene expression.
by: Dengyun Sun, et al.
Published: (2009-07-01) -
Evaluating a parainfluenza virus 5-based vaccine in a host with pre-existing immunity against parainfluenza virus 5.
by: Zhenhai Chen, et al.
Published: (2012-01-01) -
Evaluation of an attenuated vaccine candidate based on the genotype C of bovine parainfluenza virus type 3 in albino guinea pigs
by: Lei MA, et al.
Published: (2017-09-01)